Coronary heart disease
Conditions
Interventions
Experimental group:Drug gene detection of hyperlipidemia guides the treatment of lipid-lowering
Control group(YNMT)· :Traditional guidelines guide lipid-lowering therapy
Sponsors
The First Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Age =18 years old; 2. Understand the test protocol and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Severe cardiac insufficiency, acute and chronic liver and kidney disease; 2. History of trauma, surgery, stroke, and hemorrhagic disease in recent 3 months; 3. Unstable vital signs, after cardiopulmonary resuscitation; 4. Malignancy or other end-stage disease; 5. Those who fell out and lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major cardiovascular adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Low density lipoprotein reduction; | — |
Countries
China
Contacts
Public ContactHongliang Zhao
The First Hospital of Hebei Medical University
Outcome results
None listed